[1]Rajan D K, Ebner A, Desai S B, et al.Percutaneous creation of an arteriovenous fistula for hemodialysis access[J].J Vasc Interv Radiol, 2015, 26(4):484-490
[2]Lee H, Kim H, Kwon T W, et al.Effect of systemic immunosuppressive drugs on the patency of hemodialysis accesses?[J]. Clin Nephrol, 2018, 89 (2018)(1):27-33.[J].Clin Nephrol, 2018, 89(1):27-33
[3]Lee T.Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care[J].Cardiovasc Eng Technol, 2017, 8(3):244-254
[4]Shiu Y T, Rotmans J I, Geelhoed W J, et al.Arteriovenous conduits for hemodialysis: how to better modulate the pathophysiological vascular response to optimize vascular access durability[J].Am J Physiol Renal Physiol, 2019, 316(5):F794-F806
[5]杨玲, 刘斌, 于俊超, 等.维持性血液透析患者自体动静脉内瘘血栓影响因素观察[J].临床肾脏病杂志, 2016, 16(02):96-99
[6]Chisci E, Harris L M, Menici F, et al.Outcomes of three types of native arteriovenous fistula in a single center[J].J Vasc Access, 2017, 18(5):379-383
[7]叶朝阳, 戴兵.动静脉内瘘血栓的诊断和处理[J]. 肾脏病与透析肾移植杂志, 2013, 22(2).[J].肾脏病与透析肾移植杂志, 2013, 22(2):141-142
[8]Roy-Chaudhury P, Kelly B S, Zhang J, et al.Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies[J].Blood Purif, 2003, 21(1):99-110
[9]蒋晏.自体动静脉内瘘血栓形成危险因素分析[J].西南国防医药, 2013, 23(10):1078-1081
[10]Grandaliano G, Teutonico A, Allegretti A, et al.The role of hyperparathyroidism,erythropoietin therapy,and CMV infection in the failure of arteriovenous fistula in hemodialysis[J].Kidney Int, 2003, 64(2):715-719
[11]Jamshid R, Reza S A, Abbas G, et al.Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients[J].Int Urol Nephrol, 2003, 35(2):275-282
[12]Chou C Y, Kuo H L, Yung Y F, et al.C-reactive protein predicts vascular access thrombosis in hemodialysis patients[J].Blood Purif, 2006, 24(4):342-346
[13]Kirkpantur A, Arici M, Altun B, et al.Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients[J].Blood Purif, 2008, 26(4):322-332
[14]Brophy D F, Bukaveckas B L, Ferreira-Gonzalez A, et al.A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis[J].Hemodial Int, 2009, 13(1):19-26
[15]Chou C Y, Liu J H, Kuo H L, et al.The association between pulse pressure and vascular access thrombosis in chronic hemodialysis patients[J].Hypertens Res, 2009, 32(8):712-715
[16]Chang T I, Paik J, Greene T, et al.Intradialytic hypotension and vascular access thrombosis[J].J Am Soc Nephrol, 2011, 22(8):1526-1533
[17]Chou C Y, Chen J Y, Liu J H, et al.Atrial fibrillation linked to vascular access thrombosis in chronic hemodialysis patients[J].J Atheroscler Thromb, 2011, 18(6):448-453
[18]Gagliardi G M, Mancuso D, Falbo E, et al.Anthropometric parameters of nutritional assessment as predictive factors of arteriovenous fistula malfunction in patients undergoing hemodialysis[J].J Vasc Access, 2012, 13(4):475-481
[19]Salmela B, Hartman J, Peltonen S, et al.Thrombophilia and arteriovenous fistula survival in ESRD[J].Clin J Am Soc Nephrol, 2013, 8(6):962-968
[20]Stolic R V, Trajkovic G Z, Kostic M, et al.Predictive value of serum myeloperoxidase activity for thrombosis of arteriovenous fistulas[J].Hemodial Int, 2014, 18(3):680-685
[21]廖羿霖, 覃文艺, 蓝晓岚, 等.自体动静脉内瘘血栓形成的相关因素分析[J].右江医学, 2015, 43(04):444-446
[22]Androulakis N E, Tzenakis N, Nioti E, et al.Activated Protein C-Resistance Determination and Vascular Access Thrombosis in Populations with High Prevalence of Factor V Leiden[J].Nephron, 2015, 131(1):5-10
[23]杨玲, 刘斌, 于俊超, 等.维持性血液透析患者自体动静脉内瘘血栓影响因素观察[J].临床肾脏病杂志, 2016, 16(02):96-99
[24]Farber A, Imrey P B, Huber T S, et al.Multiple preoperative and intraoperative factors predict early fistula thrombosis in the Hemodialysis Fistula Maturation Study[J].J Vasc Surg, 2016, 63(1):163-170
[25]叶蔚蔚, 雷文辉, 毛明锋, 等.维持性血液透析患者动静脉内瘘血栓形成危险因素分析[J].中华现代护理杂志, 2016, 22(21):3018-3023
[26]Shin D H, Rhee S Y, Jeon H J, et al.An Increase in Mean Platelet VolumePlatelet Count Ratio Is Associated with Vascular Access Failure in Hemodialysis Patients[J].PLoS One, 2017, 12(1):e170357-e170371
[27]Ben A S, Hadj-Abdelkader M, Benezit M, et al.Predictors of Autogenous Arteriovenous Hemodialysis Access Thrombosis after Renal Transplantation[J]. Ann Vasc Surg, 2017, 42:231-237.[J].Ann Vasc Surg, 2017, (42):231-237
[28]欧月秀, 秦曙光, 林昌平, 等.血液透析病人自体动静脉内瘘失功能危险因素的回归分析[J].安徽医药, 2019, 23(01):72-75
[29]Smith G E, Gohil R, Chetter I C.Factors affecting the patency of arteriovenous fistulas for dialysis access[J].J Vasc Surg, 2012, 55(3):849-855
[30]Lazarides M K, Georgiadis G S, Antoniou G A, et al.A meta-analysis of dialysis access outcome in elderly patients[J].J Vasc Surg, 2007, 45(2):420-426
[31]Yi X, Lin J, Han Z, et al.The incidence of venous thromboembolism following stroke and its risk factors in eastern China[J].J Thromb Thrombolysis, 2012, 34(2):269-275
[32]Jiang Y, Du H, Liu J, et al.Aspirin combined with mechanical measures to prevent venous thromboembolism after total knee arthroplasty: a randomized controlled trial[J].Chin Med J (Engl), 2014, 127(12):2201-2205
[33]Lindfors O, Paldanius R.Experience with arteriovenous fistulas CIMINO in chronic hemodialysisA report on forty-five patients[J].Scand J Urol Nephrol, 1976, 10(1):80-83
[34]Lazarides M K, Iatrou C E, Karanikas I D, et al.Factors affecting the lifespan of autologous and synthetic arteriovenous access routes for haemodialysis[J].Eur J Surg, 1996, 162(4):297-301
[35]吕忠美, 朱亚梅, 顾艳红, 等.动静脉内瘘围手术期患者功能锻炼开始时间的研究[J].中华护理杂志, 2019, 54(08):1224-1228
[36]Ishimitsu T, Nakano N, Sudo Y, et al.Predictive significance of blood pressure values for the incidence of cardiovascular events in chronic hemodialysis patients[J].Hypertens Res, 2008, 31(9):1703-1709
[37]Chou J A, Streja E, Nguyen D V, et al.Intradialytic hypotension,blood pressure changes and mortality risk in incident hemodialysis patients[J].Nephrol Dial Transplant, 2018, 33(1):149-159
[38]Park J, Rhee C M, Sim J J, et al.A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival[J].Kidney Int, 2013, 84(4):795-802
[39]Denny G B, Deger S M, Chen G, et al.Leucine disposal rate for assessment of amino acid metabolism in maintenance hemodialysis patients[J]. BMC Nutr, 2016, 2.[J].BMC Nutr, 2016, 2., 2016, 2(31):-
[40]Chang T I, Paik J, Greene T, et al.Intradialytic hypotension and vascular access thrombosis[J].J Am Soc Nephrol, 2011, 22(8):1526-1533
[41]袁静, 李恒, 应金萍, 等.例血液透析患者动静脉内瘘血栓形成的原因及护理[J].中华护理杂志, 2020, 55(04):607-610
[42]Cheung A K, Imrey P B, Alpers C E, et al.Intimal Hyperplasia,Stenosis,and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study[J].J Am Soc Nephrol, 2017, 28(10):3005-3013
[43]张衡.外敷马铃薯与喜辽妥联合远红外线理疗治疗糖尿病肾病动静脉内瘘血肿的效果观察[J].国际护理学杂志, 2017, 36(20):2878-2880
[44]Vaidyula V R, Rao A K, Mozzoli M, et al.Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand[J].Diabetes, 2006, 55(1):202-208
[45]Hernández-Espinosa D, Ordó?ez A, Mi?ano A, et al.Hyperglycaemia impairs antithrombin secretion: possible contribution to the thrombotic risk of diabetes[J].Thromb Res, 2009, 124(4):483-489
[46]Cirillo P, Golino P, Calabrò P, et al.C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation[J].Cardiovasc Res, 2005, 68(1):47-55
[47]Zillmann A, Luther T, Müller I, et al.Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation[J].Biochem Biophys Res Commun, 2001, 281(2):603-609
[48]Nan B, Yang H, Yan S, et al.C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells[J].Surgery, 2005, 138(2):212-222
